Description

MeRes100^TM

• MeRes100^TM is a bioresorbable vascular scaffold system that resorbs naturally in the artery within a period of 2-3 years thus leaving the vessel in its true form and nature.
• The complete resorption prevents chance of late clinical events like restenosis. Thus, also reducing likelihood of repeat revascularization versus metallic DES.
• MeRes100 is a 2^nd generation bioresorbable technology with low strut thickness of 100microns leading to lower crossing profile for ease of delivery and early endothelialization.
• Couplets of tri-axial RO markers on both ends for enhanced visibility and large size matrix covers multitude of morphologies and lesions.

Benefits

1. Next Generation BioResorbable Scaffold: World’s first 100µm BVS
2. Ideal strut thickness to minimize vascular injury & ensure early endothelialization
3. Virtual Tubing: Couplets of tri-axial RO markers at either end of the scaffold

Product Specifications

STENT

• Stent Material and Thickness: Bioresorbable PLLA (Poly L-lactide) , 100 microns
• Stent Architecture: Hybrid Design: Closed cells on ends and open cells in middle

MATERIAL

• Drug: Sirolimus
• Drug Dose: 1.25μg/mm²
• Drug Coating: Proprietary top coat

Polymer: BIORESORBABLE PDLLA (POLY D, L-LACTIDE)

Delivery System: Rapid Exchange